Trouble With Navigation? Learn More

The Nephros Promise
We are Nephros, Inc., a modern medical device company proud to be pioneers and innovators of first-in-class therapies and products that create a better quality of life for the populations we serve. We are dedicated to providing End Stage Renal Disease patients and other immuno-compromised patients with new, innovative and efficacious therapies to improve their quality of life and to ensure the development of our company is integrated into a strategy of strong, and sustainable growth. That is our vocation at Nephros. That is our promise. We bring quality to life.

Nephros Receives FDA Approval for
Dual Stage Ultrafilters Learn More

Press Releases

RIVER EDGE, NJ May 15, 2012
Nephros Reports First Quarter Financial Results

RIVER EDGE, NJ April 30, 2012
Nephros Receives 510(k) Clearance for
Hemodiafiltration System

RIVER EDGE, NJ April 23, 2012
Nephros Appoints John C. Houghton as President
and Chief Executive Officer

RIVER EDGE, NJ April 23, 2012
Nephros Announces Strategic License and Supply
Agreement with Medica S.p.A for Ultrafiltration Products

RIVER EDGE, NJ March 22, 2012
Nephros Reports 2011 Q4 and Full Year Financial Results

RIVER EDGE, NJ February 14, 2012
Nephros Hires Director of U.S. Sales

RIVER EDGE, NJ February 10, 2012
Nephros Announces Date of its 2012
Annual Meeting of Stockholders

RIVER EDGE, NJ January 17, 2012
Nephros Receives Euro 750,000 Payment
from Bellco S.r.l

RIVER EDGE, NJ November 21, 2011
Nephros Engages Joseph S. Cervia, MD
as Strategic Consultant

RIVER EDGE, NJ November 14, 2011
Nephros Reports Q3 2011 Financial
Reports

RIVER EDGE, NJ November 10, 2011
Nephros Receives initial FDA response to
510(k) Application for Hemodiafiltration System

RIVER EDGE, NJ October 18, 2011
Nephros, Inc Post-Effective Amendment
No. 2 to Registration Statement Declared Effective

RIVER EDGE, NJ August 15, 2011
Nephros Reports Q2 2011 Financial Results

RIVER EDGE, NJ August 11, 2011
Nephros Files 510(k) Application for Hemodiafiltration System

RIVER EDGE, NJ July 26, 2011
Nephros Provides Corporate Update

RIVER EDGE, NJ July 21, 2011
Nephros Receives 510k Approval to Market Additional Ultrafiltration Products

RIVER EDGE, NJ June 27, 2011
Nephros and Bellco S.r.l. Announce License Agreement for Mid-Dilution Dialysis Products

RIVER EDGE, NJ May 16, 2011
Nephros Reports First Quarter 2011 Financial Results

RIVER EDGE, NJ May 11, 2011
Nephros Receives Approval to Market Dual Stage Ultrafilters in Canada

RIVER EDGE, NJ March 29, 2011
Nephros Reports 2010 Q4 and Full Year Financial Results

RIVER EDGE, NJ March 15, 2011
Nephros Announces Split Adjusted Trade Date

RIVER EDGE, NJ March 4, 2011
Nephros Announces $3.2 Million
Financing Through Completion of
Rights Offering and Private Placement
Transactions

RIVER EDGE, NJ February 28, 2011
Nephros Extends Rights Offering

RIVER EDGE, NJ February 11, 2011
Nephros Has Commenced Rights Offering

RIVER EDGE, NJ January 31, 2011
Nephros Rights Offering Registration
Statement Declared Effective

RIVER EDGE, NJ November 12, 2010
Nephros Reports 2010 Q3
Financial Results

RIVER EDGE, NJ October 1, 2010
Nephros Completes Bridge
Financing and Announces
Stockholder Rights Offering

RIVER EDGE, NJ August 16, 2010
Nephros Reports 2010 Second
Quarter Financial Results

RIVER EDGE, NJ July 7, 2010
Nephros Receives Formal Response
from FDA for 510 (k) Application for
Hemodiafiltration System

RIVER EDGE, NJ July 6, 2010
Nephros and AmeriWater Announce
Dual Stage Ultrafilters to be a Standard
Component of MRO Series Water
Treatment Systems

RIVER EDGE, NJ May 13, 2010
Nephros Reports 2010 Q1
Financial Results

RIVER EDGE, NJ April 2, 2010
Nephros Reports 2009 Q4 &
Full Year Financial Results

RIVER EDGE, NJ March 23, 2010
Nephros Signs Development
Agreement with STERIS

RIVER EDGE, NJ February 25, 2010
Nephros Signs Canadian Distribution
Agreement with Bellco Health Care Inc

RIVER EDGE, NJ November 12, 2009
Nephros Reports 2009 Third Quarter
Financial Results

RIVER EDGE, NJ August 31, 2009
Nephros Awarded $2 Million
by the Office of Naval Research

RIVER EDGE, NJ August 14, 2009
Nephros Reports 2009 Second Quarter
Financial Results
RIVER EDGE, NJ July 30, 2009
Nephros Completes $1.25 Million
Private Placement
RIVER EDGE, NJ July 2, 2009
Nephros Receives FDA Approval
for Dual Stage Ultrafilters

RIVER EDGE, NJ March 31, 2009
Nephros Reports 2008 Fourth Quarter
and Full Year Financial Results

RIVER EDGE, NJ February 24, 2009
Nephros provides update on 510k
application

RIVER EDGE, NJ January 26, 2009
Nephros announced that its common stock
is now quoted in the Pink Sheets under
symbol "NEPH."

RIVER EDGE, NJ January 14, 2009
Nephros Receives Notice of Intention to
Delist from AMEX

RIVER EDGE, NJ January 13, 2009
Nephros Receives 2009 Frost & Sullivan
Medical Device Patient Care Company
of the Year Award

Nephros can be found on the OTC Bulletin Board
under the ticker symbol NEPH.

Click here for additional information.